Explore › Finding
Finding adverse
Bypass-first revascularization was associated with significantly higher 30-day MACE (6.9% vs 2.6%; adjusted OR 3.88, 95% CI 2.18-6.88) and 30-day mortality (3.23% vs 1.8%; adjusted OR 2.77, 95% CI 1.26-6.11) compared with endovascular-first strategy.
Effect sizeOR 3.88
CI95% CI 2.18-6.88
Follow-up30 days
ComparatorEndovascular-first infrageniculate revascularization
Effect summaryadverse; OR 3.88; CI: 95% CI 2.18-6.88
Adverse events30-day MACE 6.9% vs 2.6%, 30-day mortality 3.23% vs 1.8%

Connected entities

Interventions
infrageniculate revascularization
Conditions
Chronic Limb-Threatening Ischemia
Outcomes
Major Adverse Cardiac Events
Populations
Older Adults

Source

PMC8906190
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease
Read on PMC → · View in graph →